Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of GTPBP1 mRNA | affects expression | 21346803
|
D003561 |
Cytarabine |
Cytarabine results in increased expression of GTPBP1 mRNA | increases expression | 19194470
|
C014347 |
decitabine |
decitabine results in increased expression of GTPBP1 mRNA | increases expression | 19194470
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol affects the expression of GTPBP1 mRNA | affects expression | 17555576
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GTPBP1 mRNA | increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP1 mRNA | affects cotreatment|increases expression | 17942748
|
D004997 |
Ethinyl Estradiol |
Ethinyl Estradiol results in increased expression of GTPBP1 mRNA | increases expression | 17108234
|
C006253 |
pirinixic acid |
pirinixic acid results in decreased expression of GTPBP1 mRNA | decreases expression | 20059764
|
C006253 |
pirinixic acid |
PPARA protein promotes the reaction [pirinixic acid results in decreased expression of GTPBP1 mRNA] | decreases expression|increases reaction | 20059764
|
D013629 |
Tamoxifen |
Tamoxifen affects the expression of GTPBP1 mRNA | affects expression | 17555576
|
D013749 |
Tetrachlorodibenzodioxin |
[Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GTPBP1 mRNA | affects cotreatment|increases expression | 17942748
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000008 |
Abdominal Neoplasms |
|
Tamoxifen |
4.99 | 14745880 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
3.24 | 15322242 14514962 11752688 |
MESH:D000152 |
Acne Vulgaris |
|
Ethinyl Estradiol |
4.38 | 17505938 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
3.42 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Ethinyl Estradiol |
1.86 | 14692618 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
11.26 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
11.26 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
3.21 | 11748828 |
MESH:D001161 |
Arteriosclerosis |
|
Ethinyl Estradiol |
3.82 | 11256880 |
MESH:D001169 |
Arthritis, Experimental |
|
Ethinyl Estradiol |
2.82 | 15885639 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
9.73 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
9.73 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
4.23 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.93 | 15746008 |
MESH:D001943 |
Breast Neoplasms |
|
decitabine |
1.87 | 19208741 18320071 |
MESH:D001943 |
Breast Neoplasms |
|
Tamoxifen |
1.87 | 19059307 20544844 19244106 19011961 16273361 20135344 19066611 19115204 20065188 11161223 16818667 17893378 20859285 19155303 17242785 15565566 19487384 19221464 18984771 15668708 20390343 18629630 20005174 19084267 19103187 18351453 17440819 16202921 21152245 18855134 17261762 16873071 19289846 19142967 17049068 19189212 19200415 19189210 19410462 18815881 19288272 18821012 18997820 18425577 21138602 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
1.87 | 20435547 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
3.02 | 16835633 |
MESH:D018270 |
Carcinoma, Ductal, Breast |
|
Tamoxifen |
4.87 | 19066611 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
3.09 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tamoxifen |
3.09 | 16924424 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
decitabine |
2.65 | 19215824 |
MESH:D002295 |
Carcinoma, Transitional Cell |
|
Tamoxifen |
3.88 | 17572228 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.50 | 18850075 18670907 16120746 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cytarabine |
4.44 | 8243401 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.41 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Ethinyl Estradiol |
8.42 | 17110522 16919318 15861022 17681005 11677210 16105132 17333356 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
8.42 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
2.20 | 15668235 8697196 12621046 16354765 15340226 |
MESH:D003110 |
Colonic Neoplasms |
|
decitabine |
2.37 | 17616700 |
MESH:D015179 |
Colorectal Neoplasms |
|
decitabine |
2.10 | 18981723 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
3.31 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.26 | 20055451 10048152 15322242 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
4.37 | 18551238 |
MESH:D003711 |
Demyelinating Diseases |
|
Tamoxifen |
4.72 | 19031437 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.53 | 18249437 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.72 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Tamoxifen |
3.72 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
3.92 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.92 | 20420201 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.96 | 11462148 |
MESH:D004487 |
Edema |
|
pirinixic acid |
7.48 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
7.48 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
4.35 | 18230668 15322242 16714409 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Ethinyl Estradiol |
10.06 | 12538720 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
Tamoxifen |
10.06 | 19031437 |
MESH:D004701 |
Endocrine Gland Neoplasms |
|
decitabine |
5.56 | 19294695 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tamoxifen |
3.21 | 19155303 17893378 20544844 16202921 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
3.29 | 9294722 10568697 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
3.21 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Ethinyl Estradiol |
14.74 | 15345470 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
14.74 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Tamoxifen |
14.74 | 19224547 14986274 |
MESH:D052776 |
Female Urogenital Diseases |
|
Tamoxifen |
3.39 | 16709447 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.81 | 11858732 |
MESH:D018221 |
Fibromatosis, Abdominal |
|
Tamoxifen |
4.92 | 14745880 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Tamoxifen |
4.58 | 19069698 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
3.31 | 20067830 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
5.04 | 10696789 |
MESH:D006258 |
Head and Neck Neoplasms |
|
decitabine |
3.66 | 19215824 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
2.46 | 11294989 10048152 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.69 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.62 | 11000095 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
9.48 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
9.48 | 15340226 16120746 12621046 |
MESH:D006689 |
Hodgkin Disease |
|
Cytarabine |
4.67 | 16200630 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
4.49 | 18606429 16959395 15340226 16354765 8697196 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.45 | 20558911 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.99 | 18670907 18850075 |
MESH:D007021 |
Hypospadias |
|
Ethinyl Estradiol |
4.17 | 16569931 16945680 |
MESH:D007247 |
Infertility, Female |
|
Ethinyl Estradiol |
3.77 | 12013081 |
MESH:D007248 |
Infertility, Male |
|
decitabine |
7.31 | 17581917 |
MESH:D007248 |
Infertility, Male |
|
Ethinyl Estradiol |
7.31 | 17937319 |
MESH:D007249 |
Inflammation |
|
Tamoxifen |
5.32 | 19457130 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
5.32 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
2.80 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.62 | 16580747 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
8.17 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Tamoxifen |
8.17 | 18625569 |
MESH:D007938 |
Leukemia |
|
decitabine |
3.19 | 18980019 19235587 |
MESH:D007951 |
Leukemia, Myeloid |
|
decitabine |
4.28 | 17236224 18454857 19117987 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
decitabine |
2.41 | 18206229 17679729 19387464 19010910 18704418 18460780 |
MESH:D015477 |
Leukemia, Myelomonocytic, Chronic |
|
decitabine |
5.91 | 18055864 |
MESH:D008064 |
Lipidoses |
|
Tamoxifen |
3.35 | 15342952 17567588 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.53 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tamoxifen |
3.53 | 18564211 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.53 | 12878042 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
7.86 | 15890375 20007298 16377806 |
MESH:D008113 |
Liver Neoplasms |
|
Tamoxifen |
7.86 | 16684651 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
7.86 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
2.26 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Tamoxifen |
2.31 | 18625569 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
2.31 | 19555203 11884234 |
MESH:D008223 |
Lymphoma |
|
decitabine |
3.61 | 19470736 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
Tamoxifen |
4.15 | 19428831 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tamoxifen |
2.79 | 14580682 16827153 11731420 19196722 19196723 |
MESH:D020149 |
Manganese Poisoning |
|
Tamoxifen |
4.99 | 19453300 |
MESH:D008545 |
Melanoma |
|
decitabine |
3.52 | 16505122 17785578 |
MESH:D008545 |
Melanoma |
|
Tamoxifen |
3.52 | 19393235 12393984 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Tamoxifen |
4.58 | 15990972 |
MESH:D009101 |
Multiple Myeloma |
|
decitabine |
3.54 | 18172295 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.86 | 16239165 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
decitabine |
3.52 | 19157545 18608210 19010910 16882708 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
2.24 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
3.24 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
3.16 | 16411023 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
4.25 | 18551238 |
MESH:D009362 |
Neoplasm Metastasis |
|
Tamoxifen |
2.64 | 19393235 |
MESH:D009364 |
Neoplasm Recurrence, Local |
|
Tamoxifen |
2.59 | 19410462 |
MESH:D009369 |
Neoplasms |
|
decitabine |
5.42 | 17925555 19116145 19470736 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
5.42 | 17405874 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
Tamoxifen |
4.44 | 19189210 19200415 19196722 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
3.54 | 14600291 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
1.86 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
3.69 | 12819281 16049721 |
MESH:D010051 |
Ovarian Neoplasms |
|
decitabine |
2.72 | 19331143 19259094 |
MESH:D010190 |
Pancreatic Neoplasms |
|
decitabine |
2.84 | 19294695 |
MESH:D016584 |
Panic Disorder |
|
Ethinyl Estradiol |
3.99 | 11578682 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.69 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.89 | 18163543 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Cytarabine |
4.58 | 21297632 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
3.59 | 11222880 11896295 11118676 11399792 |
MESH:D055728 |
Primary Myelofibrosis |
|
decitabine |
5.09 | 17616702 |
MESH:D011471 |
Prostatic Neoplasms |
|
Tamoxifen |
3.10 | 15067354 |
MESH:D011537 |
Pruritus |
|
Ethinyl Estradiol |
3.71 | 15861022 16919318 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.50 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
4.17 | 18990726 |
MESH:D012208 |
Rhabdomyosarcoma |
|
decitabine |
4.71 | 19155313 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
2.71 | 18551238 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
2.15 | 16192470 |
MESH:D013088 |
Spermatocele |
|
Ethinyl Estradiol |
13.09 | 16709447 |
MESH:D013088 |
Spermatocele |
|
Tamoxifen |
13.09 | 16709447 |
MESH:D013119 |
Spinal Cord Injuries |
|
Tamoxifen |
4.43 | 19457130 |
MESH:D013274 |
Stomach Neoplasms |
|
decitabine |
2.10 | 19037991 |
MESH:D019851 |
Thrombophilia |
|
Ethinyl Estradiol |
3.92 | 11994571 |
MESH:D013927 |
Thrombosis |
|
Ethinyl Estradiol |
3.40 | 15669648 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
4.35 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
decitabine |
3.54 | 17967635 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
8.89 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
decitabine |
8.89 | 19087683 17616700 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Tamoxifen |
8.89 | 8653321 16712894 17572228 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
4.71 | 10091137 |
MESH:D014594 |
Uterine Neoplasms |
|
Ethinyl Estradiol |
3.63 | 14692618 |
MESH:D014604 |
Uveal Neoplasms |
|
decitabine |
5.36 | 17785578 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
5.04 | 12125929 |
MESH:D020246 |
Venous Thrombosis |
|
Ethinyl Estradiol |
3.82 | 14671159 15869587 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.69 | 15886252 |